Reata Pharmaceuticals (RETA) Q2 2023 Earnings

8AugConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-2.42
-2.14
-1.86
-1.58

Details

Expected EPS
-2.09
Actual EPS
-1.58
Surprise EPS
0.51
Surprise Percent
+24.4%

Description

Reata Pharmaceuticals (RETA) has reported earnings of -1.58 per share for Q2 2023.

0 Comments

Share your thoughts